Literature DB >> 10417300

De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation.

A Tesoriero, C Andersen, M Southey, G Somers, M McKay, J Armes, M McCredie, G Giles, J L Hopper, D Venter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10417300      PMCID： PMC1377956          DOI： 10.1086/302503

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  16 in total

1.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

2.  Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer.

Authors:  Emma Edwards; Catharina Yearwood; Julie Sillibourne; Diana Baralle; Diana Eccles
Journal:  Fam Cancer       Date:  2009-07-21       Impact factor: 2.375

3.  De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.

Authors:  R B van der Luijt ; P H van Zon ; R P Jansen; C J van der Sijs-Bos ; C C Wárlám-Rodenhuis; M G Ausems
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

4.  Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.

Authors:  L Golmard; C Delnatte; A Laugé; V Moncoutier; C Lefol; K Abidallah; H Tenreiro; F Copigny; M Giraudeau; C Guy; C Barbaroux; G Amorim; A Briaux; V Guibert; J Tarabeux; S Caputo; A Collet; P Gesta; O Ingster; M-H Stern; E Rouleau; A de Pauw; M Gauthier-Villars; B Buecher; S Bézieau; D Stoppa-Lyonnet; C Houdayer
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

5.  BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.

Authors:  Christian Monnerat; Agnès Chompret; Caroline Kannengiesser; Marie-Françoise Avril; Nicolas Janin; Alain Spatz; Jean-Marc Guinebretière; Catalin Marian; Michel Barrois; Françoise Boitier; Gilbert M Lenoir; Brigitte Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2007-07-12       Impact factor: 2.375

6.  Routine TP53 testing for breast cancer under age 30: ready for prime time?

Authors:  Jeanna M McCuaig; Susan R Armel; Ana Novokmet; Ophira M Ginsburg; Rochelle Demsky; Steven A Narod; David Malkin
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

7.  A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer.

Authors:  Ava Kwong; Enders K O Ng; Edmund Y H Tang; Chris L P Wong; Fian B F Law; Candy P H Leung; Aaron Chan; M T Cheung; M Y To; Edmond S K Ma; Dee W West; James M Ford
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

8.  A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer.

Authors:  Zaida Garcia-Casado; Ignacio Romero; Antonio Fernandez-Serra; Luis Rubio; Francisco Llopis; Ana Garcia; Pilar Llombart; Jose A Lopez-Guerrero
Journal:  BMC Med Genet       Date:  2011-10-11       Impact factor: 2.103

9.  Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients.

Authors:  Ava Kwong; Enders K O Ng; Fian B F Law; H N Wong; Anna Wa; Chris L P Wong; Allison W Kurian; Dee W West; James M Ford; Edmond S K Ma
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872

10.  The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Amanda B Spurdle; Antonis C Antoniou; David L Duffy; Nirmala Pandeya; Livia Kelemen; Xiaoqing Chen; Susan Peock; Margaret R Cook; Paula L Smith; David M Purdie; Beth Newman; Gillian S Dite; Carmel Apicella; Melissa C Southey; Graham G Giles; John L Hopper; Georgia Chenevix-Trench; Douglas F Easton
Journal:  Breast Cancer Res       Date:  2004-12-16       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.